💊
Abraxane
paclitaxel
Brystneoplasmer;Pankreasneoplasmer;Ikke-småcellet lungecarcinom
✅ Autoriseret
✅
Ingen aktive alarmer
Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.
Hvad det bruges til
Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas. Abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
⚠️ Patient sikkerhed
No
📚 Tidligere alarmer (2)
Officiel EMA-side
https://www.ema.europa.eu/en/medicines/human/EPAR/abraxane